Botox Bioterror?
The Washington Times published an editorial today advocating that a French pharmaceutical company be denied access to the U.S. market because it allegedly sold “raw botulinum toxin” to Iran. The company, Ipsen, is seeking to market two Botox-alike cosmetic drugs,…
